Latest news
RenovoRx Inc (RNXT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 20:47:25 GMTRenovoRx Inc (RNXT) Stock News Today - TradingKeyTradingKey · Fri, 07 Aug 2026 18:51:16 GMTRenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors - Investing News NetworkInvesting News Network · Thu, 06 Aug 2026 22:13:08 GMTRenovoRx’s RenovoCath used in sarcoma treatment for first time - Investing.comInvesting.com · Thu, 06 Aug 2026 14:56:50 GMTRenovoRx Announces First Commercial Clinical Use Of RenovoCath In Sarcoma Patient Treatment - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 12:30:00 GMTRenovoRx to Present TAMP Platform, TIGeR-PaC Trial Update at JonesTrading Webinar Aug 13 - TradingViewTradingView · Tue, 04 Aug 2026 20:13:01 GMTRenovoRx Webinar to Explore Local Chemotherapy for Pancreatic Cancer - Stock TitanStock Titan · Tue, 04 Aug 2026 12:30:00 GMTRNXT|RenovoRx Inc|Price:1.040|Chg%:+0.082 - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMT